Journal Guide

Chemotherapy publishes original research articles and state-of-the-art reviews on all aspects of antimicrobial and antitumor chemotherapy. The results of experimental and clinical investigations into the microbiological and pharmacological properties of antibacterial, antiviral, and antitumor compounds are major topics of publication. Papers selected for the journal offer data concerning the efficacy, toxicology, and interactions of new drugs in single or combined applications. Studies designed to determine the pharmacokinetic and pharmacodynamic properties of similar preparations and comparing their efficacy are also included. Special emphasis is given to the development of drug resistance, an increasing problem worldwide.

Topics covered by the journal are: Resources of Traditional Chinese Medicines; Interaction and complexity of prescription; Natural Products Chemistry (including structure modification, semi-and total synthesis, bio-transformation); Pharmacology of natural products and prescription (including pharmacokinetics and toxicology); Pharmaceutics and Analytical Methods of natural products.

Authors should submit their manuscripts online at http://mc03.manuscriptcentral.com/cjnm, or by email to the Editorial Office, China Pharmaceutical University, at cjnm@yahoo.cn

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our http://www.elsevier.com/wps/find/authorsview.authors/authorservices author services .

Please see our http://www.elsevier.com/journals/chinese-journal-of-natural-medicines/1875-5364/guide-for-authorsGuide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

• sustainable development (economy, demography, strategy and policy, agriculture and industry, ecosystem management biodiversity),
• natural resources (water, oceans and fisheries, atmosphere, forests),
• energy (renewable consumption markets, efficiency), and
• health (poverty eradication, water and sanitation, production, technology).

Peer review policy

All published research articles in this journal have undergone rigorous peer review, based on initial editor screening and anonymous refereeing by independent expert referees.

 

STAR
Taylor & Francis/Routledge are committed to the widest possible dissemination of its journals to non-profit institutions in developing countries. Our STAR initiative offers individual researchers in Africa, South Asia and many parts of South East Asia the opportunity to gain one month’s free online access to 1,300 Taylor & Francis journals. For more information, please visit the STAR website .

Chinese Medicine, the official journal of the International Society for Chinese Medicine, is an open access, peer-reviewed online journal that encompasses all aspects of research on Chinese medicine, provided the material, methods, results, and conclusions are evidence-based, scientifically justified, and ethical.

The main aim of the journal is to publish scientific work on the role of molecular asymmetry in both biologically active and non-biologically active molecules in respect to their pharmacological, biological, and chemical properties. Drugs, pesticides, and other xenobiotics will be a major interest. Papers on the chemistry (physiochemical, preparative synthetic, and analytical), pharmacology, clinical pharmacology, toxicology, and other biological aspects of chiral molecules will be published. Among the topics to be covered are stereospecific synthesis, stereoselective analysis, preparative separation of chiral molecules, the influence of chirality on pharmacokinetics (absorption, distribution, protein binding, biotransformation, etc.), the influence of chirality on pharmacodynamics (drug-receptor interactions, pharmacological and toxicological activity), and the influence of chirality on clinical pharmacology (therapeutic index and response, bioavailability, adverse drug reactions, drug-drug interactions). Papers will also be published on regulatory and legal aspects in the development, testing, and marketing of chiral compounds. In addition to original research papers, the journal will publish brief reviews, short communications, and conference reports. Book reviews will also appear.

Clinical Cancer Drugs publishes original research and (as well as) expert reviews, and thematic issues in all core areas of translational and clinical cancer drug research.

Clinical Neuropharmacology is the leading journal of reviews and original investigations in this field. The journal is devoted to the pharmacology of the nervous system in the broadest sense, with topics ranging from basic mechanisms of action, structure-activity relationships, drug metabolism, and pharmacokinetics, to such practical clinical problems as drug interactions, drug toxicity, and the therapeutics of specific syndromes or symptoms. Disorders often classified as psychiatric, as well as classical neurological disorders, are included. Website: www.clinicalneuropharm.com.

Clinical Pharmacokinetics is the major review journal in the area of clinical pharmacokinetics, the study of drug disposition in the human body, which is an integral part of drug development and rational use.

Clinical Pharmacology & Therapeutics (CPT) is the authoritative cross-disciplinary journal in experimental and clinical medicine devoted to publishing advances in the nature, action, efficacy, and evaluation of therapeutics. CPT welcomes original Articles and Reports in the emerging areas of translational, predictive and personalized medicine; new therapeutic modalities including gene and cell therapies; pharmacogenomics, proteomics and metabolomics; bioinformation and applied systems biology complementing areas of pharmacokinetics and pharmacodynamics, human investigation and clinical trials, pharmacovigilence, pharmacoepidemiology, pharmacometrics, and population pharmacology.Commentaries and Point-Counterpoint provide a forum for perspectives in clinical pharmacology and therapeutics in the context of contemporary scientific, political, economic and social issues. State of the Art contributions summarize the latest advances in the science underpinning drug discovery, development, regulation and utilization. CPT highlights issues transforming the practice of clinical pharmacology, including ethics, education and public policy. Bench-to-bedside translation in therapeutics is presented in the context of clinical applications of basic pharmacology, discovery and translational medicine, and drug development.

Medicine/Public Health general, Gynecology, Pneumology/Respiratory system, Gastroenterology, Pediatrics

Every paper has its own priorities. Be it rapid publication, strong circulation, society affiliation or the prestige of a high Impact Factor, we help pharmaceutical companies, medcomms agencies and medical writers identify the Informa Healthcare journal that will help them achieve their publication objectives.We actively encourage pre-submission discussions with our team and Informa Healthcare editors to ensure your submission process is as efficient and effective as possible. You are welcome to contact us directly to discuss your upcoming manuscripts. Alternately, if you would like to browse our portfolio of 168 journals, you can do so using the tool below.

Clinical Therapeutics is dedicated to the dissemination of reliable and evolving evidence derived from clinical pharmacology and other therapeutic approaches to an international audience of scientists and clinicians working in a variety of research, academic, and clinical practice settings. Providing such information is especially important in this era of harmonization and globalization of drug development. Clinical Therapeutics strives to achieve its mission by providing peer-reviewed, rapid publication of recent developments in drug therapies, as well as in-depth review articles on specific agents, treatment strategies, and disease states. Most articles are available online within 20 business days after acceptance. Articles appearing in Clinical Therapeutics are indexed by all major biomedical abstracting databases.Published articles range from pivotal studies exploring new chemical entities in large, multicenter trials to those exploring repurposing of marketed agents. Additionally, pilot studies; reports that assess drug safety and tolerability in all phases of development; new routes of administration and new formulations; pharmacokinetic, bioavailability, bioequivalence and biosimilarity; and changes in practice guidelines and standards, are all of interest for publication. Clinical Therapeutics also understands the importance of strengthening the body of evidence surrounding particular agents through the publication of replication studies, negative trials, and failed trials. Beyond the clinic, we seek reports that examine the real-world implications of therapeutics such as comparative effectiveness and pharmacoeconomics studies as well as work that has implications for health policy. Commentaries, which include perspectives and contemporary issues, are sought to offer a balance of viewpoints and scholarly opinion on a broad array of drug-related topics. Case reports, which remain a vital part of our mission, offer clinically valuable lessons. All manuscripts are peer reviewed by independent clinicians or scientists for clinical relevance, technical accuracy, methodological rigor, clarity, and objectivity using a blind review process.